Athira Pharma Inc (ATHA)

$1.92 0.00 (0.00%)
16:00 EDT ATHA Stock Quote Delayed 30 Minutes

Athira Pharma (ATHA) Stock Plunges 65% on Disappointing Drug Trial Results

By William White, InvestorPlace Writer
Athira Pharma (ATHA) stock is plummeting on Wednesday following the outcome of a Phase 2 clinical trial of fosgonimeton.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Select Price, Percent change, or Dollar change as the y-axis.
Select Area, Line, OHLC or Candlestick as the chart type.
Previous Close -
Market Cap 73.06M
PE Ratio -1.27
EPS -1.51
Volume (Avg. Vol.) 164,716
Day's Range $1.91 - $2.01
52-Week Range $1.33 - $4.30
Dividend & Yield N/A (N/A)